(Q44909518)

English

Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial

scientific article

Statements

Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial (English)
Ole Schmitz
Grethe Jakobsen
David R Matthews
NN2211-1310 International Study Group
1335-1342

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit